A comparative study of vertigo chapter of Homoeopathic repertory

A COMPARATIVE STUDY TO ASSESS THE CLINICAL UTILITY OF VERTIGO CHAPTER FROM KENT REPERTORY AND BOENNINGHUSENS CHARACTRSTICS AND REPERTORY

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/043787

Enrollment

Registered

2022-07-06

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H758- Other specified disorders of middle ear and mastoid in diseases classified elsewhere

Interventions

Intervention1: Homoeopathic drugs: Individualised Homoeopathic medicine selected from kent repertory,potency and dose on thebasis of susceptibility,route ofadministration will be oral for 3 months Int

Eligibility

Inclusion criteria

Inclusion criteria: cases given consent to participate in study cases having complaint of vertigo either main or assosiated with other complains

Exclusion criteria

Exclusion criteria: pregnant women patient who are not willing to give consent cases needed emergency treatment like stroke unstable HTN uncontrolled DM uncontrolled continuous attack of vertigo

Design outcomes

Primary

Measure	Time frame
Intensity and frequency of vertigo will be assessedTimepoint: 3 months	—

Secondary

Measure	Time frame
Repertory charter comparisonTimepoint: 1 year	—

Countries

India

Contacts

Public Contactsandhya goyal

Homoeopathy university

Yashasvi119@gmail.com9783318494

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026